Eisai Sues Dr. Reddy's Over Aciphex ANDA

Law360 (November 20, 2003, 12:00 AM EST) -- The U.S. subsidiary of Japanese drugmaker Eisai has sued Indian generics maker Dr. Reddy's in the U.S. District Court for the Southern District of New York for patent infringement, after the Dr. Reddy's filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for its generic version of ulcer medicine Aciphex.

In a statement, Eisai said it believes that its rabeprazole composition of matter patent is valid until its expiration date of May 8, 2013.

On Wednesday, Dr. Reddy's said it...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.